Stock Compensation Plan (Tables)

3 Months Ended

Mar. 31, 2026

Stock Compensation Plan

Schedule of Company's Stock Options

The following table sets forth the activity for the Company’s stock options during the periods presented:


		Number of Options				Weighted- Average Exercise Price per Share				Weighted Average Remaining Contractual Term (in Years)				Aggregate Intrinsic Value
Outstanding as of December 31, 2025			808,000			$	3.06				7.3			$	2,020,050
Forfeited			(13,165	)		$	6.16
Outstanding as of March 31, 2026			794,835			$	3.00				7.0			$	1,459,260
Exercisable as of March 31, 2026			626,543			$	2.16				6.3			$	1,459,260
Vested or expected to vest as of March 31, 2026			794,835			$	3.00				7.0			$	1,459,260

Schedule of Summarizes Vesting of Restricted Common Stock

The following table summarizes vesting of restricted common stock:


		Number of Shares				Weighted Average Grant Date Fair Value Per Share
Unvested as of December 31, 2025			4,169,955			$	5.68
Vested			(495,831	)		$	5.68
Forfeited			(44,324	)		$	6.16
Unvested as of March 31, 2026			3,629,800			$	5.36

Schedule of Stock-Based Compensation Expense

Stock-based compensation expense for all stock awards recognized in the accompanying consolidated statements of operations and comprehensive loss is as follows:


		Three Months Ended March 31,
		2026				2025
Selling, general and administrative		$	4,162			$	1,819
Research and development			250				71
Total		$	4,412			$	1,890